Valbiotis SA announced the arrival of Pascal SIRVENT as Director of Discovery and Preclinical Research from September 1st, 2017. Pascal SIRVENT has been contributing to company's growth for several years as a member of the Scientific Committee and head of collaborative projects between the University of Clermont Auvergne and VALBIOTIS. Co-inventor of several technologies crucial to the development of VALBIOTIS, Pascal has extensive preclinical research expertise. He has published some 30 articles in international scientific journals and given numerous presentations at congresses. With over 10 years experience in research, Pascal SIRVENT will be bringing his in-depth expertise in metabolic diseases and nutrition.